Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
about
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infectionsApplicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of Ctrough- over Cmax-Derived Linear Regression ModelsAn evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.In Vitro Pharmacodynamics of Vancomycin against Methicillin-Susceptible and -Resistant Staphylococcus aureus: Considering the Variability in Observed Tissue Exposure.Pharmacokinetics of linezolid in critically ill patients.Is there a role for microsampling in antibiotic pharmacokinetic studies?Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.Pharmacokinetics and Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.Risk factors associated with high linezolid trough plasma concentrations.Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections.Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis.Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection
P2860
Q28394377-D7B3C65C-587D-449A-9C3F-62029CCA254EQ36620071-05D32B78-FA9A-4306-8862-0F7316A968D7Q38070154-2B3832D0-DF73-46CA-93CD-FD7E6358F904Q38367748-3B3D5DE2-808D-444B-9AC4-D405E2EB1978Q38791528-B159E9D1-7E6D-4FD0-B5E6-72614E1C4A6CQ38810590-94668F34-A471-42F6-B2C4-9CA9FAD8DCCBQ39278957-4FC66C4E-3C95-466E-A94E-A7B360888BB6Q40052714-F9ED39E9-28AF-40C8-98C3-2A8F95E71C92Q40683242-46318841-F16A-4C1A-B3B3-4DA6B0816EF1Q41172934-97423F60-2019-4188-A1A7-A8ABD7EDA011Q47611899-640CA98D-3170-4C45-85E2-118049C90695Q47647024-ADA8A5A2-6859-4726-861D-A716BFEA7399Q58788178-62B48302-48BE-46CF-94F8-7D96D60A9F34
P2860
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Determination of tissue penetr ...... s using in vivo microdialysis.
@en
type
label
Determination of tissue penetr ...... s using in vivo microdialysis.
@en
prefLabel
Determination of tissue penetr ...... s using in vivo microdialysis.
@en
P2093
P2860
P356
P1476
Determination of tissue penetr ...... s using in vivo microdialysis.
@en
P2093
Ashley Shepard
David P Nicolau
Dora E Wiskirchen
Joseph L Kuti
P2860
P304
P356
10.1128/AAC.00445-11
P407
P577
2011-06-27T00:00:00Z